Author

Lotanna Ezeja

Observed names: Ezeja, Lotanna, L. Ezeja, Lotanna V. Ezeja

Institution: Auburn University

Observed institution: Auburn University

ORCID: 0009-0006-2688-3958

Observed ORCID: 0009-0006-2688-3958

OpenAlex ID: A5115767587

Post-marketing safety of antiseizure medications: Focus on serious adverse effects including drug reaction with eosinophilia and systemic symptoms (DRESS)

2025 · Jingjing Qian, Xiangzhong Xue, et al. · Seizure · 10

Post‐marketing safety of Lantus and its interchangeable biosimilar Semglee in the United States: A disproportionality analysis using the FDA Adverse Event Reporting System ( FAERS ) database

2025 · Lotanna Ezeja, Jingjing Qian · Diabetes Obesity and Metabolism · 3

Msr132 Comparative Effectiveness of Artificial Intelligence and Machine Learning Methods Versus Traditional Disproportionality Analysis for Adverse Drug Reaction Signal Detection: a Systematic Review

2026 · Emeka E. Duru, Lotanna Ezeja, et al. · Value in Health · 1

From Trust to Choice: A Cross-Sectional Survey of How Patient Trust in Pharmacists Shapes Willingness and Vaccination Decision Control Preferences

2025 · Oluchukwu M. Ezeala, Nicholas P. McCormick, et al. · International Journal of Environmental Research and Public Health · 1

Adverse events and vaccine administration errors following RSV vaccination: Findings from the United States VAERS database, 2023–2025

2026 · Lotanna Ezeja, Oluchukwu M. Ezeala, et al. · Vaccine

Safety in Administration Errors of RSV Vaccines: Findings from the United States VAERS Data

2026 · Ezeja, Lotanna, Oluchukwu, Ezeala, et al. · Scholar Commons (University of South Carolina)

Impact of Dolutegravir-based regimens on patient satisfaction and quality of life among people living with HIV: a systematic review and meta-analysis

2026 · Mustapha Muhammed Abubakar, Christabel Ogechukwu Okoye, et al. · BMC Infectious Diseases

Ee224 Comparisons of Medical and Prescription Drug Expenditures Between Americans Who Used Insulin Glargine Lantus and Its Interchangeable Biosimilar Semglee

2026 · Lotanna Ezeja, Jingjing Qian · Value in Health

Interventions to Improve Breast Cancer Preventive Medication Treatment Uptake: A Systematic Review

2026 · Sara K. Jaradat, Lotanna Ezeja, et al. · American Journal of Preventive Medicine

Cancer treatment-related risk factors for stroke among patients with lung cancer: A systematic review and meta-analysis

2026 · Lotanna Ezeja, Sara Jaradat, et al. · Cancer Treatment and Research Communications

1084 Exploring the impact of Patient Trust in Community Pharmacists on Vaccination Decision-Making Preferences During Shared Clinical Decision-Making

2025 · O. Ezeala, L. Ezeja, et al. · Journal of the American Pharmacists Association

HPR39 Health Insurance Use Among Young Pharmacists in Nigeria

2025 · Cynthia C. Egbuemike, Azeez B. Aina, et al. · Value in Health

Author response for "Post‐marketing safety of Lantus and its interchangeable biosimilar Semglee in the United States: A disproportionality analysis using the FDA Adverse Event Reporting System ( FAERS ) database"

2025 · Lotanna Ezeja, Jingjing Qian · Publons reviews and discussion

Works count: 13

Citation count: 15

H-index: 2

I10-index: 1